FGF2 and breast carcinoma: In this context, Hu Y.’s data suggest that miR-205 is able to target VEGF-A and FGF2 in breast cancer cells, impairing the PI3K/AKT signaling and thus triggering apoptosis and the restoration of chemo-sensitivity in resistant BC cells [33].